SPY312.23+1.71 0.55%
DIA258.42+1.11 0.43%
IXIC10,207.63+53.00 0.52%

SunTrust Robinson Humphrey Initiates Coverage On Genmab with Buy Rating, Announces $28 Price Target

SunTrust Robinson Humphrey analyst Asthika Goonewardene initiates coverage on Genmab (NASDAQ:GMAB) with a Buy rating and a $28 price target.

Benzinga · -

SunTrust Robinson Humphrey analyst Asthika Goonewardene initiates coverage on Genmab (NASDAQ:GMAB) with a Buy rating and a $28 price target.